June 12, 2024

Extracorporeal Shock Wave Lithotripsy Market Poised To Grow At A Robust Pace Due To Rising Prevalence Of Kidney Stones

Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive medical procedure used to treat stones present in the kidney, ureter or gallbladder. During ESWL, shock waves, which are high-energy sound waves, are targeted to the kidney stones from outside of the body. The shock waves help in breaking the stones into smaller fragments which can pass out of the body naturally through urine. Compared to surgical methods like ureteroscopy and percutaneous nephrolithotomy, ESWL offers less discomfort and shorter hospital stay to patients. It has revolutionized the management and treatment of urinary stones and gallstones worldwide over the last few decades.

The global Extracorporeal Shock Wave Lithotripsy Market is estimated to be valued at Us$ 510.34 Mn in 2024 and is expected to exhibit a CAGR Of 7.2% over the forecast period 2024 to 2030.

Key Takeaways

– Key players operating in the extracorporeal shock wave lithotripsy market are William Grant & Sons, Pernod Ricard, Diageo Plc, Bacardi Limited, Suntory Holdings, Aceo Ltd., Ben Nevis Distillery, Edrington, Louis Vuitton Mo√ęt Hennessy and Gordon & MacPhail.

– Rising prevalence of urolithiasis and gallstones globally is expected to present lucrative growth opportunities for players in the extracorporeal shock wave lithotripsy market over the forecast period.

– Major players are focusing on expanding their geographic presence in developing regions such as Asia Pacific and Latin America to tap the high growth opportunities in these regions.

Market Drivers

– Increasing incidence of kidney stone disease globally is a major factor augmenting market growth. As per the National Kidney Foundation estimates, about 1 in 11 people will develop kidney stones at some point during their lifetime.

– Technological advancements in ESWL lithotripsy systems, such as the introduction of electrohydraulic, electromagnetic and piezoelectric lithotripters has enhanced stone fragmentation rates and treatment effectiveness, thereby driving their adoption.

– Growing preference for minimally invasive surgeries over traditional open surgeries is favoring the demand for ESWL procedures for treating urinary calculi.

 

PEST Analysis

Political: The extracorporeal shock wave lithotripsy market is subject to various government regulations regarding medical device approval and marketing. Stringent approval processes can impact the entry of new devices and therapies in this market.

Economic: Growth in disposable incomes and rising health insurance coverage are increasing patient spending capabilities on advanced stone treatment options like extracorporeal shock wave lithotripsy. Its cost-effectiveness over invasive surgeries also supports market growth.

Social: Rising awareness about kidney stone risks and available treatment choices is encouraging more patients to opt for minimally invasive treatments such as extracorporeal shock wave lithotripsy. The non-invasive nature of this therapy makes it a widely accepted solution.

Technological: Continuous technological advances are helping design more effective and efficient lithotripters. Features like improved imaging capabilities and the use of ultrasound or laser for targeted stone fragmentation are enhancing treatment outcomes. Product upgrades also aim to reduce the risk of recoilment and retreatment needs.

Geographical regions where market in terms of value is concentrated:

Global Extracorporeal Shock Wave Lithotripsy Market North America region currently holds the largest share of the extracorporeal shock wave lithotripsy market, mainly due to the high prevalence of kidney stone cases in the United States. The growing adoption of advanced lithotripters and favorable reimbursement policies also contribute to the high consumption in this regional market.

Fastest growing region for the market:

The Asia Pacific region is expected to grow at the fastest rate during the forecast period due to rising medical tourism, increasing healthcare investments, and growing awareness. The rising patient volumes in highly populous countries like China and India present substantial opportunities. Furthermore, growing collaborations between global and local players will increase the availability of high-quality lithotripters in Asia’s developing markets.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it